Clinical Trials Directory

Trials / Completed

CompletedNCT02770235

Evaluation of Advanced Glycation End-products (AGE) and the Erectile Dysfunction (DE) in Diabetic Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
97 (actual)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

In diabetics there is an abnormally increased production of AGEs due to hyperglycemia. An association was shown between AGE measured by biopsy (invasive) and DE patients with diabetes (increase of AGE level in the corpora cavernosa). To date no studies have explored the link between DE and the measure of AGE by a non-invasive method of Auto-fluorescence (AF) Skin (AGEReaderTM). If the hypothesis of an association between DE and AGE measured by AF was checked, screening for erectile dysfunction and measurement of AGEs could help to improve the overall management of diabetic patient (including cardiovascular) and their quality of life.

Conditions

Interventions

TypeNameDescription
OTHERDE assessmentby a validated self-administered questionnaire: Index International erectile function (IIEF-15)
OTHERAGE measurementBy AGE-ReaderTM

Timeline

Start date
2014-03-17
Primary completion
2019-03-16
Completion
2019-03-16
First posted
2016-05-12
Last updated
2025-09-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02770235. Inclusion in this directory is not an endorsement.